RGLS (Regulus Therapeutics Inc) Yalpi marja

Regulus (RGLS) korporativ emblemasi va logotipi

Regulus Therapeutics (RGLS) global sog'liqni saqlash gigantlari bilan strategik ittifoqlar orqali klinik sinovlarni tezlashtirmoqda. Valo profit marjasi moliyaviy dinamikani aniq namoyish etadi, bunda 0.00 ko'rsatkichi metrikaning holatini ifodalaydi. Nukleotid sintezini avtomatlashtirish ichki tadqiqotlarni optimallashtirib, ilmiy xodimlar sonini kamaytiradi. microRNA uchun patentlar va polikistoz buyrak kasalligi terapiyasining 1-fazasidagi ijobiy natijalar fundamental salohiyatni mustahkamlaydi.

Regulus Therapeutics Inc - RGLS Yalpi marja (davr: 04.07.2022 - 05.07.2025)

Regulus Therapeutics Inc (RGLS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Regulus Therapeutics, Inc. ishlab chiqargan mahsulot

Polikistoz buyrak kasalligini davolash uchun innovatsion RNK dori vositalarini ishlab chiqish xarajatlarining yuqoriligini hisobga olgan holda, investorlar Regulus Therapeutics (RGLS) modelining barqarorligini baholashlari kerak. Bioteknologiya sektori uchun tushum va bevosita ishlab chiqarish xarajatlari o'rtasidagi farq kritik ahamiyatga ega, chunki u aktivlar kapitalizatsiyasining samaradorligini belgilaydi. Vald rentabelligini tahlil qilish orqali operatsion xarajatlarni qoplash va biznesni yanada kengaytirish uchun mavjud bo'lgan foyda qismini aniqlash mumkin.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda bo'yicha rentabellik Tempus AI Inc|QGEN (Qiagen NV) - Yalpi marja|Yalpi foyda bo'yicha rentabellik Ionis Pharma (IONS)|Yalpi rentabellik Repligen Corp (RGEN)|RNA - Yalpi foyda marjasi|crisprtx.com - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi WGS|RARE - Yalpi rentabellik|Beam Tx (BEAM) - Yalpi foyda bo'yicha rentabellik|SRPT (Sarepta Therapeutics Inc) - Yalpi foyda bo'yicha rentabellik|TWST: Yalpi foyda koeffitsiyenti|TXG (10xgenomics.com) - Yalpi marja|NTLA (Intellia Therapeutics, Inc.) - Yalpi foyda koeffitsiyenti|Yalpi rentabellik Stoke Corp (STOK)|Yalpi foyda bo'yicha sotuv rentabelligi BioLife|Yalpi marja WVE (Wave Life Sciences Ltd)|MAZE: Sotuvning yalpi rentabelligi|Sionna Therapeutics, Inc. - Yalpi marja|Yalpi foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Yalpi foyda bo'yicha rentabellik|QURE - Yalpi foyda bo'yicha sotuv rentabelligi|MGTX (MeiraGTx Corp) - Yalpi marja|Yalpi foyda marjasi REGENXBIO Inc. RGNX|Yalpi rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Sotuvning yalpi rentabelligi|Yalpi rentabellik Pacific Biosciences PACB|Yalpi foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Yalpi marja|Rocket Pharmaceuticals - Yalpi foyda koeffitsiyenti|Sotuvning yalpi rentabelligi 4D Molecular Therapeutics, Inc.|Yalpi foyda marjasi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Yalpi marja|Yalpi foyda marjasi Editas EDIT|Yalpi marja SLN|ProQR Therapeutics - Sotuvning yalpi rentabelligi|Yalpi marja CDXS (Codexis, Inc.)|SGMO: Sotuvning yalpi rentabelligi|Nautilus Biotechnology - Yalpi marja|Yalpi foyda normasi MGX (Metagenomi, Inc)|DTIL: Yalpi marja|GBIO: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Boundless Bio Inc.|Yalpi foyda bo'yicha rentabellik Exicure (XCUR)|Yalpi marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Yalpi foyda normasi|Mustang Bio, Inc. - Yalpi foyda bo'yicha rentabellik|RNAZ - Yalpi foyda bo'yicha rentabellik|BNGO: Yalpi foyda bo'yicha rentabellik|APDN (Applied DNA Sciences Inc) - Sotuvning yalpi rentabelligi|BLUE (Bluebird Bio) - Yalpi foyda bo'yicha rentabellik|ImmunoPrecise Antibodies Ltd - Yalpi foyda normasi|OMGA (Omega Therapeutics Inc) - Yalpi marja|Yalpi rentabellik OMIC|Yalpi rentabellik Syros Pharmaceuticals Inc. (SYRS)|Yalpi foyda bo'yicha sotuv rentabelligi Codex DNA|Yalpi rentabellik TRACON TCON|Unity Biotechnology, Inc - Yalpi rentabellik